Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2002
10/31/2002WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/31/2002WO2002026769A3 Haplotypes of the casp5 gene
10/31/2002WO2002024912A3 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
10/31/2002WO2002016566A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/31/2002WO2002016023A3 Method and apparatus for in situ synthesis on a solid support
10/31/2002WO2002010392A3 Mammalian dna binding membrane-associated protein-encoding gene and uses
10/31/2002WO2002000262A3 Modulation of chromosome function by chromatin remodeling agents
10/31/2002WO2001094635A3 Integrated active flux microfluidic devices and methods
10/31/2002WO2001075165A3 Screening markers and methods for neurodegenerative disorders
10/31/2002WO2001075067A9 Novel nucleic acids and polypeptides
10/31/2002WO2001071028A3 Specific multiplex analysis of nucleic acids
10/31/2002WO2001068913A3 Nucleic acid detection method and system
10/31/2002WO2001061356A9 Her-2 binding antagonists
10/31/2002WO2001059152A3 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
10/31/2002WO2001057251A9 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
10/31/2002WO2001055432A3 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/31/2002WO2001055369A9 Synthetic internal ribosome entry sites and methods of identifying same
10/31/2002WO2001054814A9 Compositions and methods for performing biological reactions
10/31/2002WO2001051633A9 Compositions and methods for the therapy and diagnosis of prostate cancer
10/31/2002US20020162126 Methods and compositions for RNA interference
10/31/2002US20020161599 Electronic database of enzyme substrate and enzyme inhibitor structures
10/31/2002US20020161215 For use in assays designed to identify and characterize compounds which affect the function of such receptors, e.g., agonists and antagonists of NMDA receptors
10/31/2002US20020161213 Novel human kinases and polynucleotides encoding the same
10/31/2002US20020161212 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
10/31/2002US20020161208 Useful for diagnosing, therapy, prophylaxis and/or prognosing disorders related to these novel polypeptides
10/31/2002US20020161196 Trail receptors nucleic acids encoding the same and methods of use thereof
10/31/2002US20020161195 Trail receptors, nucleic acids encoding the same, and methods of use thereof
10/31/2002US20020161193 Useful for the production of NMDA receptor subunit proteins, these nucleic acids are also useful as probes, to identify and isolate related human receptor subunits
10/31/2002US20020160978 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
10/31/2002US20020160977 Method for selective inactivation of viral replication
10/31/2002US20020160976 Method for selective inactivation of viral replication
10/31/2002US20020160972 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
10/31/2002US20020160969 Nucleosides and oligonucleotides containing boron clusters
10/31/2002US20020160968 Inhibitor of niacinamide phosphoribosyl transferase (NAPRT)
10/31/2002US20020160940 Modulation of endogenous gene expression in cells
10/31/2002US20020160933 Methods and compositions for producing a neurosalutary effect in a subject
10/31/2002US20020160915 Altering the ATP gradient across the membrane of a target cell by inhibiting an extracellular phosphatase (ecto-phosphatase) in the target cell
10/31/2002US20020160517 Distinguishing test types through spectral analysis
10/31/2002US20020160514 Expression vector system and a method for optimization and confirmation of DNA delivery and quantification of targeting frequency
10/31/2002US20020160503 Method for the separation of adsorbents from microbiological growth media
10/31/2002US20020160499 For use in diagnosis, prophylaxis, and therapy of disorders associated with expression of serine carboxypeptidase
10/31/2002US20020160497 For use in detection and treatment of the disease, breast cancer, prostate cancer, testicular cancer, ovarian cancer, uterine cancer cervical cancer, and colon cancer
10/31/2002US20020160493 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
10/31/2002US20020160490 For screening physiologically active substances using serine protease or DNA that codes for it
10/31/2002US20020160487 Testis specific transcription factor ZGCL-1
10/31/2002US20020160485 Polynucleotide motor, a motor system, their preparation and uses
10/31/2002US20020160484 Central nervous system disorders therapy; genetic engineering
10/31/2002US20020160481 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
10/31/2002US20020160478 Short peptides which selectively modulate the activity of protein kinases
10/31/2002US20020160477 CAF1-related protein
10/31/2002US20020160476 Genetic engineeering; binding to antibodies
10/31/2002US20020160463 Phagemid for antibody screening
10/31/2002US20020160457 Immobilizated antigens; cloning gene sequence; electroporation; calibration
10/31/2002US20020160448 Human c-Maf compositions and methods of use thereof
10/31/2002US20020160443 Method and apparatus for computer controlled rare cell, including fetal cell, based diagnosis
10/31/2002US20020160442 Quantitative analysis
10/31/2002US20020160441 Protein elongation factor 2 as a target for antifungal and antiparasitic agents
10/31/2002US20020160440 Vapor phase decontamination process biological indicator evaluator resistomer (BIER) vessel
10/31/2002US20020160439 Chromogenic substrate to detect urine adulteration
10/31/2002US20020160438 Modulate kinase; antiinflammatory agents; respiratory system disorders
10/31/2002US20020160436 Method and apparatus for determining biologically useful field metrics associated with magnetic fields
10/31/2002US20020160433 Diagnosis of urogenital disorders
10/31/2002US20020160415 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for the prevention of cancer in at- risk subjects
10/31/2002US20020160409 Hybrid chromosome detector; cancer detection
10/31/2002US20020160408 Detection interaction between proteins
10/31/2002US20020160407 Method of diagnosing and treating pneumonia and pneumonia-related sepsis associated with the IL6-174 gene polymorphism
10/31/2002US20020160406 Method for using unequal primer concentrations for generating nucleic acid amplification products
10/31/2002US20020160404 Tumor diagnosis
10/31/2002US20020160403 huBUB3 gene involved in human cancers
10/31/2002US20020160402 Linear and circular expression elements
10/31/2002US20020160401 Biochip and method of designing probes
10/31/2002US20020160400 Radiative decay engineering
10/31/2002US20020160396 Labeling with organoplatinum compound
10/31/2002US20020160395 Detection of survivin in the biological fluids of cancer patients
10/31/2002US20020160393 Controlling gene expression in eukaryotic cells
10/31/2002US20020160392 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/31/2002US20020160391 Reversible binding of molecules to metal substrates through affinity interactions
10/31/2002US20020160390 Polymorphic DNAs and their use for diagnosis of susceptibility to panic disorder
10/31/2002US20020160388 Compositions and methods relating to lung specific genes and proteins
10/31/2002US20020160387 Compositions and methods relating to ovary specific genes and proteins
10/31/2002US20020160386 Methods of using transporter-like molecules to treat pain and pain-related disorders
10/31/2002US20020160385 Detection of diseases; calibration alleles
10/31/2002US20020160384 Polypeptides; binding to antibodies
10/31/2002US20020160383 Use of nucleic acid analogues in diagnostics and analytical procedures
10/31/2002US20020160382 Detection cell differentiation gene expression
10/31/2002US20020160381 Colorimetric analysis detection; using gold or silver particles
10/31/2002US20020160380 Combinatorial libraries by recombination in yeast and analysis method
10/31/2002US20020160379 Gapped 2' modified oligonucleotides
10/31/2002US20020160378 Detection hybrids; cell differentiation; gene expression;
10/31/2002US20020160376 Amplification of sample; variations of alleles; electrophoresis
10/31/2002US20020160374 Fusion protein; genetic engineering; binding to antibodies
10/31/2002US20020160373 PCR materials and methods useful to detect canine and feline lymphoid malignancies
10/31/2002US20020160372 Veterinary medicine; screening animal for litter size; polymerase chain reaction; amplification
10/31/2002US20020160365 Compositions and methods for the early diagnosis of ovarian cancer
10/31/2002US20020160364 Detection of bactericides; therapy for bacteria infections
10/31/2002US20020160363 Magnetic-based placement and retention of sensor elements in a sensor array
10/31/2002US20020160362 Measurement variations of allele polypeptides gene; diagnosis of arthritis, cancer
10/31/2002US20020160361 Amplification; separation; detection; forming drug libraries
10/31/2002US20020160360 Hybrid analysis; target binding efficiency
10/31/2002US20020160359 Stabilizing diluent for polypeptides and antigens
1 ... 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 ... 3003